The estimated Net Worth of Edward T Schafer is at least $693 millier dollars as of 10 June 2014. Mr. Schafer owns over 795 units of Cellular Biomedicine Inc stock worth over $270,674 and over the last 14 years he sold CBMG stock worth over $331,928. In addition, he makes $89,903 as Non-Executive Independent Director at Cellular Biomedicine Inc.
Sign up
Mr. Schafer CBMG stock SEC Form 4 insiders trading
Edward has made over 2 trades of the Cellular Biomedicine Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 795 units of CBMG stock worth $115,625 on 10 June 2014.
The largest trade he's ever made was selling 1,945 units of Cellular Biomedicine Inc stock on 24 December 2013 worth over $216,303. On average, Edward trades about 183 units every 11 days since 2010. As of 10 June 2014 he still owns at least 13,705 units of Cellular Biomedicine Inc stock.
You can see the complete history of Mr. Schafer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Edward Schafer biography
Edward T. Schafer serves as Non-Executive Independent Director of the Company. He has served on audit and compensation committees for public companies and has deep experience in strategic planning in both the private and public sectors. Mr. Schafer has served as vice chairman of Bion Environmental Technologies Inc., an agriculture technology company, since 2011. Mr. Schafer is Co-Founder of Extend America, a rural America wireless communication company. He is a board member of AGCO-Amity JV, and Vice Chairman of Amity Technology LLP, agricultural equipment companies, and serves on the board of Northstar Capital Partners LLC, a financial services company. Mr. Schafer is also Chairman of Dynamic Food Ingredients, and a board member of the Center for Innovation at the University of North Dakota and teaches a leadership class at North Dakota State University. Mr. Schafer was elected as governor of the State of North Dakota in two consecutive terms, is a past chair of the Republican Governors Association, the Midwestern Governors’ Association, the Interstate Oil and Gas Compact, the Western Governors’ Association and served as the 29th United States Secretary of Agricultural from 2008 to 2009. Mr. Schafer holds a Master’s degree in Business Administration from the University of Denver. In considering Mr. Schafer’s eligibility to serve on the Board, the Board considered Mr. Schafer’s business acumen, administration and management experience in the public and private sectors.
What is the salary of Edward Schafer?
As the Non-Executive Independent Director of Cellular Biomedicine Inc, the total compensation of Edward Schafer at Cellular Biomedicine Inc is $89,903. There are 7 executives at Cellular Biomedicine Inc getting paid more, with Andrew Chan having the highest compensation of $847,684.
How old is Edward Schafer?
Edward Schafer is 74, he's been the Non-Executive Independent Director of Cellular Biomedicine Inc since 2019. There are no older and 9 younger executives at Cellular Biomedicine Inc.
What's Edward Schafer's mailing address?
Edward's mailing address filed with the SEC is C/O CELLULAR BIOMEDICINE GROUP, INC., 9605 MEDICAL CENTER DR, SUITE 100, ROCKVILLE, MD, 20850.
Insiders trading at Cellular Biomedicine Inc
Over the last 13 years, insiders at Cellular Biomedicine Inc have traded over $5,441,696 worth of Cellular Biomedicine Inc stock and bought 262,367 units worth $1,621,804 . The most active insiders traders include Keith Wong, Wei (William) Cao et Pak To Venture Garden Ltd F.... On average, Cellular Biomedicine Inc executives and independent directors trade stock every 84 days with the average trade being worth of $911,976. The most recent stock trade was executed by Wen Tao Liu on 10 April 2018, trading 22,444 units of CBMG stock currently worth $348,555.
What does Cellular Biomedicine Inc's logo look like?
Complete history of Mr. Schafer stock trades at Cellular Biomedicine Inc, Continental Resources Inc (OKLA) et Tidal Trust II
Cellular Biomedicine Inc executives and stock owners
Cellular Biomedicine Inc executives and other stock owners filed with the SEC include:
-
Andrew Chan,
Senior Vice President - Corporate Business Development, General Counsel, Chief Legal Officer, Secretary -
Bizuo Liu,
Chief Executive Officer, Chief Financial Officer, Director -
Yihong Yao,
Chief Scientific Officer -
Wen Liu,
Independent Director -
Terry Belmont,
Independent Chairman of the Board -
Hansheng Zhou,
Independent Director -
Chun Kwok Alan Au,
Independent Director -
Edward Schafer,
Non-Executive Independent Director -
Gang Ji,
Independent Director -
Sarah Kelly,
Director of Corporate Communications -
Darren O'Brien,
Independent Director -
Health Investment Holdings ...,
-
Wei (William) Cao,
Chief Executive Officer -
Bosun Hau,
-
Tony Liu,
CEO, CFO -
Nadir Patel,
-
Pak To Venture Garden Ltd F...,
-
David Bolocan,
Director -
Keith Wong,
Director -
Jianping Dai,
Director